Pattern of anti-malarial drugs and artemether combination therapy adherence in an institution based medical centre, Nigeria
1Department of pharmacology and toxicology, faculty of pharmaceutical sciences, Nnamdi Azikiwe University Awka, Anambra state, Nigeria.
2 Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, University of Benin, Nigeria, ikponmwosa.
3 Immunology Department, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Anambra state, Nigeria.
Research Article
World Journal of Advanced Research and Reviews, 2020, 08(03), 162-170
Article DOI: 10.30574/wjarr.2020.8.3.0437
Publication history:
Received on 12 November 2020; revised on 22 November 2020; accepted on 25 November 2020
Abstract:
The change in policy guidelines for treating uncomplicated malaria became necessary because the therapeutic efficacy of chloroquine and SP had deteriorated. Hence compliance is a necessity to enable effective check on malaria. This work was carried out to evaluate antimalaria drug prescription and to update its usage in line with WHO guideline on Artemeter Combination therapy in a university based medical center. We utilized descriptive, cross-sectional, retrospective study of antimalaria prescriptions purposely carried out among male and female outpatients with mean age of 22.4±2.8 at a University health facility. This comprised all outpatients prescriptions that contained at least one antimalarial drug filed from October 2018 to September 2019. Systematic sampling was used to select the prescriptions. Based on the total number of 1250 prescriptions containing at least one antimalarial drug, a sampling interval of 5 was calculated and simple balloting was used for the first pick. A total number of two hundred and fifty (250) prescriptions containing at least one antimalarial drug were selected for the study. Out of 250 antimalaria prescriptions, usage of ACT class of Artemeter lumefantrine, Artemeter Amodiaquine and Artemeter Piparaqiune were recorded at 45.6%, 10.4% and 9.6% respectively. Triple combination Artemeter lumefantrine and Sulphadoxine-Pyrimethamine was recorded at 20.4% while Sulphadoxine-Pyrimethamine was recorded at 4%. Combination of antimalarial drugs with antibiotics was recorded at 31.2%. This study showed compliance with National Antimalarial Treatment Guideline for the treatment of malaria infection as it regards the use of artemisinin-based combination therapy. The frequency usage of artemeter lumefantrine was proceeding among other ACTs. The frequency in co-prescription of antibiotics with anti-malaria should be guarded to comply with WHO recommendation.
Keywords:
Anti- malarial; Prescription Pattern; Policy Adherence; Clinical Responses Artemether Combination
Full text article in PDF:
Copyright information:
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0